SEC Form 4 · accession 0001651844-15-000007
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Dec 7, 2015
Accepted (ET)
Dec 11, 2015 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 7, 2015 | P | 10,000 | $3.31 | A | 2,387,550 | D | |
| Common Stock | Dec 7, 2015 | P | 10,000 | $3.27 | A | 2,397,550 | D | |
| Common Stock | Dec 8, 2015 | P | 2,478 | $3.30 | A | 2,400,028 | D | |
| Common Stock | Dec 9, 2015 | P | 10,000 | $3.61 | A | 2,410,028 | D | |
| Common Stock | Dec 11, 2015 | P | 7,000 | $4.07 | A | 2,417,028 | D | |
| Common Stock | Dec 11, 2015 | P | 7,334 | $3.53 | A | 2,424,362 | D | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust | |
| Common Stock | holding | — | — | — | 45,050 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.